Loading organizations...
§ Venture Capital · Shanghai, Shanghai, China
Liwick Investment Management functions as a focused capital provider, primarily engaging in investment rounds for growth-stage companies. The firm strategically allocates capital, with a notable emphasis on the biotechnology sector, participating in significant funding for innovators. Its operational model involves identifying and backing enterprises poised for development and expansion.
Details regarding Liwick Investment Management's founders or precise inception remain largely unpublicized. The firm emerged as a financial entity deploying capital into private companies, driven by an interest in fostering innovation and growth. It gained recognition for participating in later-stage funding rounds, providing substantial capital.
Companies benefiting from Liwick's involvement are typically those seeking substantial funding for scaling operations or advanced R&D, particularly within biotech. Liwick Investment Management’s vision centers on generating financial returns by supporting groundbreaking ventures, aiming to contribute to market advancements through its investment portfolio.
Liwick Investment Management has 1 tracked investment across 1 company. The latest tracked deal is $45.6M Series C in Eden Biologics in May 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 12, 2015 | Eden Biologics | $45.6M Series C | — | Milestone Capital, Sungent BioVenture |